NCT07778394NARecruiting

Personalized Addiction Treatment enHancement

Rhode Island Hospital

Start Date

8/13/2026

Completion Date

3/31/2027

Summary

Many patients stop medication-based treatments for Opioid Use Disorder (OUD) prematurely, placing them at increased risk for overdose and death. Providing targeted interventions for OUD, particularly through an accessible, digital health platform, is a potential way to enhance recovery and keep patients engaged in care. The current study seeks to test whether a digital mental health platform, delivered by peer recovery support specialists to individuals prescribed buprenorphine or methadone medication, will improve treatment outcomes for this high risk population.

Eligibility Criteria

Age Range: 22 years to No maximum

Inclusion Criteria: * Age 22+ * Current Opioid Use Disorder diagnosis * Prescribed buprenorphine or methadone * Initiated or reinitiated buprenorphine or methadone treatment recently * Access to personal smartphone Exclusion Criteria: * Not fluent in English * Limited mental capacity or inability to provided informed consent

Interventions

BEHAVIORAL

Vira Platform

BEHAVIORAL

Treatment-As-Usual

Interested in This Trial?

Contact the trial locations directly using the information below to learn more about enrollment.

Expressing interest lets you review the study and consent before we connect you with the research site.

Conditions

Opioid Use DisordermHealthPeer Support

Locations

Rhode Island Hospital

Providence, Rhode Island 02903

United States